Status:
UNKNOWN
Does Insulin Requirement Post Cardiac Surgery Predicts The Risk Of Developing Diabetes
Lead Sponsor:
Hamad Medical Corporation
Conditions:
Diabetes
Pre-diabetes
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The patient outcome in cardiac surgery is substantially linked to the occurrence of hyperglycemia. Qatar ranks 5th in the rate of diabetes globally; Moreover diabetics comprise more than 40% of patien...
Detailed Description
Critically ill patients frequently suffer from acute hyperglycemia, (a blood glucose level of more than 6.1 mmol/L (110 mg/dL)) and is observed in around 90 percent of ICU patients. Additionally, insu...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 1-Adult patients above the age of 18 years subjected to cardiac surgery,
- Exclusion criteria:
- Diabetics.
- Patients who refuse to participate or who /can not sign informed consent.
Exclusion
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04765982
Start Date
December 1 2021
End Date
December 31 2023
Last Update
February 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamad medical corporation
Doha, DA, Qatar, 3050